COYA (Coya Therapeutics) FCF Yield % : -15.60 (As of Jul. 21, 2025)

View and export this data going back to 2022. Start your Free Trial

What is Coya Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Coya Therapeutics's Trailing 12-Month Free Cash Flow is $-15.26 Mil, and Market Cap is $97.84 Mil. Therefore, Coya Therapeutics's FCF Yield % for today is -15.60%.

The historical rank and industry rank for Coya Therapeutics's FCF Yield % or its related term are showing as below:

COYA' s FCF Yield % Range Over the Past 10 Years
Min: -17.66 Med: -10.01 Max: -3.77
Current: -15.6

During the past 5 years, the highest FCF Yield % of Coya Therapeutics was -3.77%. The lowest was -17.66%. And the median was -10.01%.

COYA's FCF Yield % is ranked worse than
56.51% of 1483 companies
in the Biotechnology industry
Industry Median: -12.25 vs COYA: -15.60

Coya Therapeutics's FCF Margin % for the quarter that ended in Mar. 2025 was -1,096.12%.

Coya Therapeutics FCF Yield % Historical Data

The historical data trend for Coya Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coya Therapeutics FCF Yield % Chart

Coya Therapeutics Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Yield %

-15.78

-10.48

-10.75

Coya Therapeutics Quarterly Data
	Dec20	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
FCF Yield %	Get a 7-Day Free Trial										5.85	-19.79	-22.25	-10.07	-10.45

Competitive Comparison of Coya Therapeutics's FCF Yield %

For the Biotechnology subindustry, Coya Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Coya Therapeutics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Coya Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Coya Therapeutics's FCF Yield % falls into.

Save Embed

;

Save Embed

;

Coya Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Coya Therapeutics's FCF Yield % for the fiscal year that ended in Dec. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-10.289	/	95.73111
	=	-10.75%

Coya Therapeutics's annualized FCF Yield % for the quarter that ended in Mar. 2025 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-2.828	*	4	/	108.21075
	=	-10.45%

Coya Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Coya Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Coya Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Coya Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Coya Therapeutics Inc (NAS:COYA) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

5850 San Felipe Street, Suite 500, Houston, TX, USA, 77057

Website

https://www.coyatherapeutics.com

Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.

Executives

David S Snyder	officer: Chief Financial Officer	ONE SCIENCE COURT, MADISON WI 53711
Fred Grossman	officer: Chief Medical Officer	C/O COYA THERAPEUTICS, INC., 5850 SAN FELIPE ST., SUITE 500, HOUSTON TX 77057
Ann Lee	director	C/O COYA THERAPEUTICS, INC., 5850 SAN FELIPE ST., SUITE 500, HOUSTON TX 77057
Dieter Weinand	director	C/O REPLIMUNE GROUP, INC., 18 COMMERCE WAY, WOBURN MA 01801
Goldstein Dov A Md	director
Adrian Hepner	officer: Chief Medical Officer	C/O COYA THERAPEUTICS, INC., 5850 SAN FELIPE ST., SUITE 500, HOUSTON TX 77057
Hideki Garren	director	C/O PROTHENA BIOSCIENCES INC, 331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO CA 94080
Anabella Villalobos	director	C/O COYA THERAPEUTICS, INC., 5850 SAN FELIPE ST., SUITE 500, HOUSTON TX 77057
Howard Berman	director, 10 percent owner, officer: Chief Executive Officer	C/O COYA THERAPEUTICS, INC., 5850 SAN FELIPE ST., SUITE 500, HOUSTON TX 77057
Bertex Llc	10 percent owner	5850 SAN FELIPE ST., SUITE 500, HOUSTON TX 77057